{"hands_on_practices": [{"introduction": "The power of an enzyme lies in its ability to dramatically lower the activation energy of a reaction. This exercise provides a foundational calculation based on transition state theory, allowing you to directly quantify how a specific reduction in the Gibbs free energy of activation, $\\Delta G^{\\ddagger}$, translates into an immense increase in reaction rate. Mastering this relationship is the first step toward understanding enzyme efficiency and the principles of rational drug design. [@problem_id:2149417]", "problem": "A team of bioengineers is working on creating a synthetic enzyme to catalyze a slow but crucial step in the production of a new pharmaceutical. According to transition state theory, an enzyme accelerates a reaction by specifically stabilizing the high-energy transition state complex. After synthesizing their candidate enzyme, the team measures its catalytic effect. They find that, at an operating temperature of $300 \\text{ K}$, the enzyme lowers the Gibbs free energy of activation for the reaction by $20.0 \\text{ kJ} \\cdot \\text{mol}^{-1}$ compared to the uncatalyzed reaction in the same solvent. Assuming the pre-exponential factors in the rate equations are identical for the catalyzed and uncatalyzed reactions, by what factor does this synthetic enzyme increase the reaction rate?\n\nUse the value of the universal gas constant as $R = 8.314 \\text{ J} \\cdot \\text{mol}^{-1} \\cdot \\text{K}^{-1}$. Report your answer as a dimensionless number rounded to three significant figures.", "solution": "Transition state theory (Eyring equation) gives the rate constant as\n$$\nk = A \\exp\\!\\left(-\\frac{\\Delta G^{\\ddagger}}{R T}\\right),\n$$\nwhere $A$ is the pre-exponential factor. If the pre-exponential factors are identical for catalyzed and uncatalyzed reactions, the rate enhancement factor is the ratio\n$$\n\\frac{k_{\\text{cat}}}{k_{\\text{uncat}}} = \\exp\\!\\left(-\\frac{\\Delta G^{\\ddagger}_{\\text{cat}} - \\Delta G^{\\ddagger}_{\\text{uncat}}}{R T}\\right).\n$$\nGiven that the enzyme lowers the activation free energy by $20.0 \\text{ kJ} \\cdot \\text{mol}^{-1}$, we have $\\Delta G^{\\ddagger}_{\\text{cat}} = \\Delta G^{\\ddagger}_{\\text{uncat}} - 20.0 \\times 10^{3} \\text{ J} \\cdot \\text{mol}^{-1}$, so\n$$\n\\frac{k_{\\text{cat}}}{k_{\\text{uncat}}} = \\exp\\!\\left(\\frac{20.0 \\times 10^{3}}{R T}\\right).\n$$\nSubstituting $R = 8.314 \\text{ J} \\cdot \\text{mol}^{-1} \\cdot \\text{K}^{-1}$ and $T = 300 \\text{ K}$,\n$$\n\\frac{k_{\\text{cat}}}{k_{\\text{uncat}}} = \\exp\\!\\left(\\frac{20.0 \\times 10^{3}}{8.314 \\times 300}\\right) = \\exp\\!\\left(\\frac{20000}{2494.2}\\right) \\approx \\exp(8.0186).\n$$\nEvaluating the exponential and rounding to three significant figures,\n$$\n\\frac{k_{\\text{cat}}}{k_{\\text{uncat}}} \\approx 3.04 \\times 10^{3}.\n$$\nThus, the synthetic enzyme increases the reaction rate by a factor of approximately $3.04 \\times 10^{3}$.", "answer": "$$\\boxed{3.04 \\times 10^{3}}$$", "id": "2149417"}, {"introduction": "Building on the fundamental link between energy and rate, we now explore how specific molecular interactions contribute to catalysis. This problem uses the scenario of a site-directed mutation to quantify the energetic contribution of a single hydrogen bond that exclusively stabilizes the transition state. By calculating the resulting decrease in catalytic efficiency, you will gain a deeper appreciation for how an enzyme's precisely arranged active site achieves its function. [@problem_id:2149421]", "problem": "An enzyme, \"Fructofuranoside Kinase\" (FK), catalyzes the phosphorylation of a sugar substrate. In the enzyme's active site, a glutamine residue at position 212 (Gln212) plays a crucial role. Structural studies have revealed that the side chain of Gln212 forms a single hydrogen bond with an oxygen atom of the phosphate group, but *only* when the substrate is in its high-energy transition state. This interaction is absent when the substrate is in its ground state bound to the enzyme.\n\nA research team creates a mutant version of FK where Gln212 is replaced by a valine residue (a Gln212Val mutation). Valine has a nonpolar side chain and cannot form the stabilizing hydrogen bond. Assume this is the only consequence of the mutation.\n\nThe Gibbs free energy of stabilization provided by this single hydrogen bond to the transition state is determined to be $15.5 \\text{ kJ} \\cdot \\text{mol}^{-1}$. The experiments are conducted at a standard physiological temperature of 310.15 K. Use the ideal gas constant, $R = 8.314 \\text{ J} \\cdot \\text{mol}^{-1} \\cdot \\text{K}^{-1}$.\n\nCalculate the factor by which the catalytic rate, represented by $k_{cat}$, is reduced in the Gln212Val mutant compared to the wild-type enzyme. Express your answer as a dimensionless number rounded to three significant figures.", "solution": "The problem asks for the factor by which the catalytic rate ($k_{cat}$) is reduced due to a mutation. This factor is the ratio of the wild-type rate constant to the mutant rate constant, $\\frac{k_{cat, WT}}{k_{cat, mut}}$.\n\nAccording to transition state theory, the catalytic rate constant $k_{cat}$ is exponentially related to the Gibbs free energy of activation, $\\Delta G^\\ddagger$. The relationship is given by the Eyring equation:\n$$ k_{cat} = \\kappa \\frac{k_B T}{h} \\exp\\left(-\\frac{\\Delta G^\\ddagger}{RT}\\right) $$\nwhere $\\kappa$ is the transmission coefficient (often assumed to be 1), $k_B$ is the Boltzmann constant, $h$ is Planck's constant, $T$ is the absolute temperature, and $R$ is the ideal gas constant.\n\nWe can write the rate constants for the wild-type (WT) and mutant (mut) enzymes as:\n$$ k_{cat, WT} = C \\exp\\left(-\\frac{\\Delta G^\\ddagger_{WT}}{RT}\\right) $$\n$$ k_{cat, mut} = C \\exp\\left(-\\frac{\\Delta G^\\ddagger_{mut}}{RT}\\right) $$\nwhere $C = \\kappa \\frac{k_B T}{h}$ is a pre-exponential factor that is the same for both enzymes, as the temperature and fundamental constants are identical.\n\nThe problem states that the wild-type enzyme has a glutamine residue that stabilizes the transition state by forming a hydrogen bond, providing a stabilization energy $\\Delta E_{H-bond} = 15.5 \\text{ kJ} \\cdot \\text{mol}^{-1}$. This stabilization *lowers* the activation energy barrier for the wild-type enzyme relative to a state without that bond. The mutant enzyme lacks this stabilizing interaction. Therefore, the activation energy for the mutant is higher than for the wild-type enzyme. The difference in activation energies is equal to the stabilization energy provided by the hydrogen bond:\n$$ \\Delta G^\\ddagger_{mut} - \\Delta G^\\ddagger_{WT} = \\Delta E_{H-bond} $$\nNow we can compute the ratio of the rate constants:\n$$ \\frac{k_{cat, WT}}{k_{cat, mut}} = \\frac{C \\exp\\left(-\\frac{\\Delta G^\\ddagger_{WT}}{RT}\\right)}{C \\exp\\left(-\\frac{\\Delta G^\\ddagger_{mut}}{RT}\\right)} $$\nThe pre-exponential factors $C$ cancel out:\n$$ \\frac{k_{cat, WT}}{k_{cat, mut}} = \\exp\\left(-\\frac{\\Delta G^\\ddagger_{WT}}{RT} - \\left(-\\frac{\\Delta G^\\ddagger_{mut}}{RT}\\right)\\right) = \\exp\\left(\\frac{\\Delta G^\\ddagger_{mut} - \\Delta G^\\ddagger_{WT}}{RT}\\right) $$\nSubstituting the difference in activation energy:\n$$ \\frac{k_{cat, WT}}{k_{cat, mut}} = \\exp\\left(\\frac{\\Delta E_{H-bond}}{RT}\\right) $$\nNow, we plug in the given values. It is crucial to ensure the units are consistent. The energy $\\Delta E_{H-bond}$ is given in kJ/mol, while the gas constant $R$ is in J·mol⁻¹·K⁻¹. We must convert kJ to J.\n\nGiven values:\n$\\Delta E_{H-bond} = 15.5 \\text{ kJ} \\cdot \\text{mol}^{-1} = 15500 \\text{ J} \\cdot \\text{mol}^{-1}$\n$R = 8.314 \\text{ J} \\cdot \\text{mol}^{-1} \\cdot \\text{K}^{-1}$\n$T = 310.15 \\text{ K}$\n\nFirst, calculate the value of the exponent:\n$$ \\frac{\\Delta E_{H-bond}}{RT} = \\frac{15500 \\text{ J} \\cdot \\text{mol}^{-1}}{(8.314 \\text{ J} \\cdot \\text{mol}^{-1} \\cdot \\text{K}^{-1})(310.15 \\text{ K})} $$\n$$ \\frac{\\Delta E_{H-bond}}{RT} = \\frac{15500}{2578.4591} \\approx 6.0113 $$\nNow, calculate the final ratio:\n$$ \\frac{k_{cat, WT}}{k_{cat, mut}} = \\exp(6.0113) \\approx 408.01 $$\nThe problem asks for the answer to be rounded to three significant figures.\n$$ 408.01 \\approx 408 $$\nSo, the catalytic rate is reduced by a factor of approximately 408.", "answer": "$$\\boxed{408}$$", "id": "2149421"}, {"introduction": "The principles of transition state stabilization are a cornerstone of modern drug design, guiding the creation of highly potent inhibitors. This practice problem puts you in the role of a biochemist tasked with evaluating a potential drug candidate hypothesized to be a transition state analog. By analyzing experimental kinetic data, you will calculate the key parameters $K_M$ and $K_i$ to determine just how much more tightly the inhibitor binds than the natural substrate, providing quantitative evidence for its mechanism. [@problem_id:2149462]", "problem": "A research team is developing a new drug to target a critical bacterial enzyme, \"Glucohydrolase,\" which breaks down a specific sugar substrate. They have synthesized a compound, \"Statin-X,\" which they hypothesize acts as a transition state analog. To test this hypothesis, they perform a series of kinetic experiments.\n\nFirst, they characterize the enzyme with its natural substrate. The Michaelis-Menten kinetics are observed. At a substrate concentration of $40.0$ micromolar ($\\mu$M), the initial reaction velocity ($v_0$) is measured to be $75.0$ nanomoles per minute (nM/min). At saturating substrate concentrations, the maximum velocity ($V_{max}$) is determined to be $150.0$ nM/min.\n\nNext, they perform an experiment in the presence of the inhibitor. Based on the transition-state analog hypothesis, the team assumes Statin-X acts as a competitive inhibitor. They measure the initial reaction velocity in a solution containing $40.0$ $\\mu$M of the substrate and $2.00$ $\\mu$M of Statin-X. The observed initial velocity is $25.0$ nM/min.\n\nTo quantify the effectiveness of Statin-X as a potential transition-state analog, calculate the ratio of the Michaelis constant of the substrate ($K_M$) to the inhibition constant of Statin-X ($K_i$). Report your answer as a dimensionless numerical value, rounded to three significant figures.", "solution": "The goal of this problem is to calculate the ratio $\\frac{K_M}{K_i}$ from the provided kinetic data.\n\n**Step 1: Determine the Michaelis constant ($K_M$) for the substrate.**\n\nThe Michaelis-Menten equation describes the initial reaction velocity ($v_0$) as a function of substrate concentration ($[S]$):\n$$v_0 = \\frac{V_{max}[S]}{K_M + [S]}$$\nThe Michaelis constant, $K_M$, is defined as the substrate concentration at which the reaction velocity is half of the maximum velocity ($V_{max}$).\n\nFrom the problem statement, we are given:\n- Maximum velocity, $V_{max} = 150.0$ nM/min.\n- At a substrate concentration $[S] = 40.0$ $\\mu$M, the initial velocity is $v_0 = 75.0$ nM/min.\n\nWe can see that the measured velocity ($75.0$ nM/min) is exactly half of the maximum velocity ($150.0$ nM/min).\n$$v_0 = \\frac{V_{max}}{2} = \\frac{150.0 \\, \\text{nM/min}}{2} = 75.0 \\, \\text{nM/min}$$\nBy the definition of $K_M$, the substrate concentration that yields this half-maximal velocity is equal to $K_M$. Therefore, we can directly determine $K_M$ from the given data.\n$$K_M = 40.0 \\, \\mu\\text{M}$$\n\n**Step 2: Determine the inhibition constant ($K_i$) for the inhibitor Statin-X.**\n\nThe problem states that Statin-X is assumed to be a competitive inhibitor. For competitive inhibition, the Michaelis-Menten equation is modified as follows:\n$$v_0 = \\frac{V_{max}[S]}{\\alpha K_M + [S]}$$\nwhere $\\alpha$ is a factor that describes the effect of the inhibitor, defined as:\n$$\\alpha = 1 + \\frac{[I]}{K_i}$$\nHere, $[I]$ is the concentration of the inhibitor and $K_i$ is the inhibition constant.\n\nFrom the problem, we have the data for the inhibited reaction:\n- Initial velocity, $v_0 = 25.0$ nM/min.\n- Substrate concentration, $[S] = 40.0$ $\\mu$M.\n- Inhibitor concentration, $[I] = 2.00$ $\\mu$M.\n- We also use the previously determined constants: $V_{max} = 150.0$ nM/min and $K_M = 40.0$ $\\mu$M.\n\nWe can substitute these values into the equation for competitive inhibition to solve for $\\alpha$.\n$$25.0 = \\frac{150.0 \\times 40.0}{\\alpha(40.0) + 40.0}$$\n$$25.0 = \\frac{6000}{40.0(\\alpha + 1)}$$\n$$25.0 = \\frac{150.0}{\\alpha + 1}$$\nNow, we rearrange to solve for $\\alpha$:\n$$\\alpha + 1 = \\frac{150.0}{25.0}$$\n$$\\alpha + 1 = 6.00$$\n$$\\alpha = 5.00$$\n\nNow that we have the value of $\\alpha$, we can use its definition to find $K_i$:\n$$\\alpha = 1 + \\frac{[I]}{K_i}$$\n$$5.00 = 1 + \\frac{2.00 \\, \\mu\\text{M}}{K_i}$$\n$$4.00 = \\frac{2.00 \\, \\mu\\text{M}}{K_i}$$\n$$K_i = \\frac{2.00 \\, \\mu\\text{M}}{4.00}$$\n$$K_i = 0.500 \\, \\mu\\text{M}$$\n\n**Step 3: Calculate the ratio $\\frac{K_M}{K_i}$.**\n\nFinally, we calculate the ratio of the two constants we have found.\n$$ \\frac{K_M}{K_i} = \\frac{40.0 \\, \\mu\\text{M}}{0.500 \\, \\mu\\text{M}} $$\n$$ \\frac{K_M}{K_i} = 80.0 $$\nThe units ($\\mu$M) cancel out, leaving a dimensionless ratio. The problem asks for the answer to three significant figures. The value $80.0$ has three significant figures.", "answer": "$$\\boxed{80.0}$$", "id": "2149462"}]}